265 related articles for article (PubMed ID: 6306041)
1. Differing effects of metoclopramide and adrenocorticotropin on plasma aldosterone levels in glucocorticoid-suppressible hyperaldosteronism and other forms of hyperaldosteronism.
Ganguly A; Pratt JH; Weinberger MH; Grim CE; Fineberg NS
J Clin Endocrinol Metab; 1983 Aug; 57(2):388-92. PubMed ID: 6306041
[TBL] [Abstract][Full Text] [Related]
2. Adrenal steroid responses to ACTH in glucocorticoid-suppressible aldosteronism.
Ganguly A; Weinberger MH; Guthrie GP; Fineberg NS
Hypertension; 1984; 6(4):563-7. PubMed ID: 6086520
[TBL] [Abstract][Full Text] [Related]
3. Plasma aldosterone response to ACTH in primary aldosteronism and in patients with low renin hypertension.
Kem DC; Weinberger MH; Higgins JR; Kramer NJ; Gomez-Sanchez C; Holland OB
J Clin Endocrinol Metab; 1978 Apr; 46(4):552-60. PubMed ID: 225341
[TBL] [Abstract][Full Text] [Related]
4. Effects of metoclopramide, a dopamine antagonist, on secretion of aldosterone and renin release in patients with primary aldosteronism.
Mizuno K; Yamazaki M; Ikeda K; Yaginuma K; Hashimoto S; Fukuchi S
Jpn Heart J; 1983 Nov; 24(6):917-24. PubMed ID: 6323781
[TBL] [Abstract][Full Text] [Related]
5. Dopaminergic regulation of aldosterone secretion: assessment in different subtypes of primary aldosteronism and in essential hypertension.
Veglio F; Pinna G; Rabbia F; Panarelli M; Bisbocci D; Melchio R; Chiandussi L
J Int Med Res; 1991; 19(1):44-9. PubMed ID: 1850365
[TBL] [Abstract][Full Text] [Related]
6. Study on clinical and endocrine characteristics of dexamethasone-suppressible hyperaldosteronism compared with those in primary aldosteronism owing to aldosterone-producing adenoma.
Yamakita N; Yasuda K; Noritake N; Mercado-Asis LB; Murase H; Mune T; Morita H; Miura K
Acta Endocrinol (Copenh); 1989 Sep; 121(3):334-44. PubMed ID: 2552725
[TBL] [Abstract][Full Text] [Related]
7. Renin-aldosterone response to dexamethasone in glucocorticoid-suppressible hyperaldosteronism is altered by coexistent renal artery stenosis.
Stowasser M; Gordon RD; Klemm SA; Tunny TJ
J Clin Endocrinol Metab; 1993 Sep; 77(3):800-4. PubMed ID: 8396580
[TBL] [Abstract][Full Text] [Related]
8. Long term evolution of glucocorticoid-suppressible hyperaldosteronism.
Stockigt JR; Scoggins BA
J Clin Endocrinol Metab; 1987 Jan; 64(1):22-6. PubMed ID: 3536983
[TBL] [Abstract][Full Text] [Related]
9. Altered 11 beta-hydroxylase activity in glucocorticoid-suppressible hyperaldosteronism.
Jamieson A; Ingram MC; Inglis GC; Davies E; Fraser R; Connell JM
J Clin Endocrinol Metab; 1996 Jun; 81(6):2298-302. PubMed ID: 8964867
[TBL] [Abstract][Full Text] [Related]
10. [Primary dexamethasone-suppressible hyperaldosteronism and hyperprolactinemia].
Veglio F; Pinna G; Rabbia F; Mulatero P; Chiandussi L
Minerva Endocrinol; 1992; 17(1):43-6. PubMed ID: 1323053
[TBL] [Abstract][Full Text] [Related]
11. 10. Hypertension. A comparison of the effects of angiotensin II infusion and variations in salt intake on plasma aldosterone levels in normal subjects, patients with essential hypertension and patients with hyperaldosteronism.
Zoccali C; Usherwood T; Brown JJ; Lever AF; Robertson JI; Fraser R
J Steroid Biochem; 1983 Jul; 19(1A):327-31. PubMed ID: 6310234
[TBL] [Abstract][Full Text] [Related]
12. Adrenocorticotropin-mediated effect of metoclopramide on plasma aldosterone in man.
Nishida S; Matsuki M; Nagase Y; Horino M; Endoh M; Kakita K; Tenku A; Oyama H
J Clin Endocrinol Metab; 1983 Nov; 57(5):981-5. PubMed ID: 6311868
[TBL] [Abstract][Full Text] [Related]
13. The role of ACTH in the episodic release of aldosterone in patients with idiopathic adrenal hyperplasia, hypertension, and hyperaldosteronism.
Kem DC; Weinberger MH; Gomez-Sanchez C; Higgins JR; Kramer NJ
J Lab Clin Med; 1976 Aug; 88(2):261-70. PubMed ID: 182890
[TBL] [Abstract][Full Text] [Related]
14. Overproduction of sodium-retaining steroids by the zona glomerulosa is adrenocorticotropin-dependent and mediates hypertension in dexamethasone-suppressible aldosteronism.
Gill JR; Bartter FC
J Clin Endocrinol Metab; 1981 Aug; 53(2):331-7. PubMed ID: 6265487
[TBL] [Abstract][Full Text] [Related]
15. Effect of metoclopramide on plasma aldosterone in normal subjects, primary aldosteronism and hypopituitarism.
Mantero F; Opocher G; Boscaro M; Valpione E; Armanini D; Fallo F
Horm Metab Res; 1981 Aug; 13(8):464-7. PubMed ID: 7035323
[TBL] [Abstract][Full Text] [Related]
16. Primary aldosteronism: effects of inhibition of ACTH and potassium administration on plasma aldosterone concentration.
Ganguly A; Luetscher JA; Weinberger MH
Clin Exp Hypertens A; 1982; 4(9-10):1695-714. PubMed ID: 6291813
[TBL] [Abstract][Full Text] [Related]
17. Circadian rhythm of plasma aldosterone concentration in patients with primary aldosteronism.
Kem DC; Weinberger MH; Gomez-Sanchez C; Kramer NJ; Lerman R; Furuyama S; Nugent CA
J Clin Invest; 1973 Sep; 52(9):2272-7. PubMed ID: 4353776
[TBL] [Abstract][Full Text] [Related]
18. Control of plasma aldosterone in primary aldosteronism: distinction between adenoma and hyperplasia.
Ganguly A; Melada GA; Luetscher JA; Dowdy AJ
J Clin Endocrinol Metab; 1973 Nov; 37(5):765-75. PubMed ID: 4356136
[No Abstract] [Full Text] [Related]
19. Pituitary peptides other than ACTH may not be aldosterone secretagogue in primary aldosteronism.
Miyamori I; Koshida H; Matsubara T; Soma R; Takasaki H; Okamoto S; Takeda R
Exp Clin Endocrinol; 1990 Aug; 95(3):323-9. PubMed ID: 2174003
[TBL] [Abstract][Full Text] [Related]
20. Reduced response to metoclopramide and anomalous rising response to upright posture of plasma aldosterone concentration in Japanese patients with aldosterone-producing adenoma.
Mune T; Morita H; Yasuda K; Yamakita N; Miura K
J Clin Endocrinol Metab; 1993 Oct; 77(4):1020-7. PubMed ID: 8408449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
